Strengths
The strengths of our ancillary study were the long duration of interventional and observational periods. The implementation of an observational period after completion of interventional program allowed to assess long-term cognitive effect and its potential durability. In our knowledge, this work is the first analysis—to date—that assessed cognitive effect of a non-pharmacological intervention considering amyloid status defined by blood-based biomarkers.